Foreign Drug Makers Seeking to Offset Risk in US, European Markets by Driving Growth in “Attractive” Japanese Market

Drug makers have announced their FY2013 settlements of accounts. According to IMS Japan, the domestic drug market grew just 3.1% from January through December 2013 despite the lack of an NHI price revision, poor growth compared to 2011 (+6.9%) and...read more